by admin_prosemble | 15th October 2025 | News
Prosemble has been awarded funding through the Innovate UK Biomedical Catalyst (BMC) Femtech & AI in Health: Feasibility Competition 2025. The grant will support research into targeted drug delivery for EGFR-positive lung cancer using protein nanoparticles and...
by admin_prosemble | 15th October 2025 | News
Inna Zhuranskaya attended Supercharging Innovation in AI, Data Science, and Health Care, which brought together leaders from government, academia, and industry to explore how the UK can accelerate innovation in health care. The event featured welcome remarks from...
by admin_prosemble | 10th October 2025 | News
On 10 October, Inna Zhuranskaya attended the TCS Good Growth Event in collaboration with Exponent Women. This year marks the fifth anniversary of the event — a milestone celebration bringing together leaders, investors, and innovators to discuss growth, technology,...
by admin_prosemble | 2nd October 2025 | News
Inna Zhuranskaya attended the HSBC Innovation Banking Oncology Innovation Day, which brought together venture investors, pharmaceutical leaders, innovators, government representatives, and other industry thought leaders. Notable speakers included: Steve Bates OBE...
by admin_prosemble | 23rd September 2025 | News
The Prosemble team recently attended the Pioneer Group Summer Graduate Soirée, an event celebrating innovation, networking, and collaboration across the life sciences and technology sectors. During the event, team members met with: Tiffany Thorn, Founder & CEO of...
by admin_prosemble | 5th September 2025 | News
We’re delighted to announce a significant expansion of the Prosemble team as we continue to grow our capabilities across both AI and life sciences. Please join us in welcoming our newest colleagues and consultants: Tamara Veres – AI/Bioinformatics Specialist (Dry Lab)...
